Loading search results
SSVC-PILOT
Sponsor study identifier
interventional
20
1 country
1
Study Start
September 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
September 23, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
September 23, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
This study will pilot a newly developed Syntactic-Semantic Visual Configuration Intervention (SSVCI) designed to help Urdu-speaking children with language impairment improve their ability to understand and produce phrases and sentences. The intervention was developed through extensive literature review, expert recommendations, and the structure of the Urdu language to ensure that it is appropriate for children in Pakistan. Before pilot testing, experts in speech-language pathology and Urdu linguist according to the inclusion criteria reviewed the intervention material to evaluate whether the activities are relevant, culturally appropriate, and representative of the language skills being taught. Feedback from children and caregivers was also be used to in the first phase of need assessment, before the intervention material was finalized. The pilot study will include 20 children aged 6 to 12 years, including 10 children with language impairment and 10 children with typical language development. Participants will be recruited from selected schools, hospitals, and special education centers in Islamabad. Children with language impairment conditions , with primary diagnosis of autism spectrum disorder, hearing impairment, cerebral palsy, or Down syndrome, provided they meet the study eligibility criteria will be included. Participants will complete language assessments before taking part in the intervention activities. These assessments will measure language skills such as sentence formation, understanding of spoken language, and narrative abilities. Information collected during the pilot study will help researchers determine whether the intervention materials are clear, practical, culturally appropriate, and suitable for use in a larger clinical trial. Findings from this study will also be used to refine the intervention by identifying activities or items that require modification or removal before final implementation.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 23, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 27, 2026
Actual (reported)August 26, 2026
Actual (reported)September 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
September 23, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
September 23, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Outcome 1: Change in Narrative Performance (MAIN)
Description: Narrative language performance will be assessed using the Urdu version of the Multilingual Assessment Instrument for Narratives (MAIN). At baseline and post-intervention, each participant will be presented with a standardized six-picture narrative sequence and will be asked to produce the corresponding story. Narrative production will be scored according to the standardized MAIN Urdu scoring criteria, including story structure and structural complexity. Narrative comprehension will be assessed using the standardized MAIN comprehension questions administered following the narrative task. For each participant, the MAIN narrative production score and narrative comprehension score will be calculated according to the instrument's predefined scoring criteria. Higher scores indicate better narrative production and/or comprehension performance. The outcome will be evaluated as the change in MAIN scores from baseline to immediately after completion of the intervention.
Baseline and immediately after completion of the 16 intervention sessions (approximately 8 weeks).
Outcome Measure 2 Title: Change in Mean Length of Utterance in Words Derived from the Narrative Language Sam
Participants will receive the Syntactic-Semantic Visual Configuration Intervention (SSVCI), a structured, visually supported Urdu language intervention designed to improve syntactic and semantic language skills in children with language impairment. The intervention consists of 16 individual therapy sessions delivered by a qualified speech-language pathologist, two to three times per week, with each session lasting approximately 30 minutes. The intervention progresses from foundational language concepts to early grammatical structures using visual configuration cues and structured language activities.
The Syntactic-Semantic Visual Configuration Intervention (SSVCI) is a structured, therapist-delivered language intervention developed specifically for Urdu-speaking children with language impairment. The intervention integrates syntactic and semantic language instruction with a visual configuration system that uses standardized visual cues to facilitate language comprehension and expressive language production. Therapy progresses systematically from foundational language concepts to early grammatical structures, including question forms, descriptive language, location concepts, negation, and plural forms. The intervention is culturally and linguistically tailored to Urdu and is delivered individually by a qualified speech-language pathologist in sixteen 30-minute sessions conducted two to three times per week.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Child Development Center
Rawalpindi, Federal, 44000, Pakistan
Humaira Shamim Kiyani, Phd
Riphah International University
First Submitted
July 27, 2026
First Posted
August 26, 2026
Study Start
September 1, 2026
Estimated (date passed)Description Description: Mean Length of Utterance in words (MLU-w) will be calculated from each participant's recorded narrative language sample obtained during the story-production task at baseline and after completion of the intervention. The participant's narrative will be audio-recorded and transcribed verbatim. The transcript will be segmented into utterances using predefined language-sample segmentation rules. MLU-w will be calculated as: MLU-w = Total number of words produced ÷ Total number of utterances A separate MLU-w value will be calculated for each participant at baseline and post-intervention. The outcome will be the change in MLU-w from baseline to post-intervention, with a higher MLU-w indicating production of longer utterances and greater expressive syntactic complexity.
Baseline and immediately after completion of the 16 intervention sessions (approximately 8 weeks).
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
September 23, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
September 23, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
August 26, 2026
Record last verified: 2026-08
Individual participant data will not be shared because the study involves a small sample of children, and sharing individual-level data may increase the risk of participant identification. Results will be reported in aggregate form to protect participant confidentiality and privacy. There are no current plans to share individual participant data. Study findings will be published in aggregate form, and participant confidentiality will be maintained in accordance with institutional ethics requirements.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: